DOC reports strong FY’24/25 results with 26% sales growth and resumed dividends. Despite recent share price drops, we see a 34% upside potential to € 234 DCF-based PT.

27 Jun 2025
FY'24/25 targets reached and dividend resumed; chg. analyst

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
FY'24/25 targets reached and dividend resumed; chg. analyst
- Published:
27 Jun 2025 -
Author:
Henry Wendisch -
Pages:
7 -
DOC reports strong FY’24/25 results with 26% sales growth and resumed dividends. Despite recent share price drops, we see a 34% upside potential to € 234 DCF-based PT.